More Clinical Articles


Benefits Realized From Genome Research Set To Increase

Lucy Brake, (Jun 17, 2013)

The U.S. Supreme Court’s ruling last week that naturally occurring human genes cannot be patented is believed to help advance the push of technology toward greater affordability and help drive costs lower.

EMA Releases Final Guidance on Biosimilars, Seeks Comment

Ben Steele, (Jun 17, 2013)

The EMA has released the last of a series of three proposed guidelines on biosimilar medicines for public six-month consultation.

ABPI Demands More NHS Data on New Medicine Uptake

Ben Steele, (Jun 13, 2013)

The ABPI has called for the NHS to provide more data on the uptake and access to new medicines in the UK. This follows the second publication of the NHS’s ‘Innovation Scorecard,’ a measure of how quickly different NHS trusts are adopting the latest NICE-approved treatments and drugs.

UK Cancer Care Revolutionised with New Database Launch

Louise Kelly, (Jun 13, 2013)

The world’s largest cancer database had been unveiled in England, raising hopes of an increase in a personalized approach to treating this disease.

Breakthrough Anti-Cancer Mechanism Could Lead to a New Drug Strategy for this Disease

Anonymous, (Jun 12, 2013)

A fundamental discovery of the vital triggers of a cancer-blocking mechanism in cells could lead to the creation of a new treatment strategy for this disease.

Another Bill Calls For Clinical Trial Data Transparency

Zuzanna Fimińska, (Jun 11, 2013)

A US Congressman has introduced legislation requiring study results of all clinical trials – positive and negative – to be registered at, with failure to comply resulting in loss of eligibility for grants.

Glaxo Dismisses Employee over Fabricated Data

Zuzanna Fimińska, (Jun 11, 2013)

GlaxoSmithKline dismisses Jingwu Zang, senior VP and head of R&D in Shanghai, one of key authors of a paper based on fabricated data, about the role of a protein called interleukin-7 in autoimmune disease.

Boehringer Latest Expansion Adds to China’s Bio-Boom

Louise Kelly, (Jun 11, 2013)

Boehringer Ingelheim has signed a deal with Zhangjiang Biotech & Pharmaceutical Base Development company, to build an advanced biopharmaceuticals facility in Pudong, Shanghai.

New Initiative Aims for “World Free of Cancer by 2050”

Ben Steele, (Jun 6, 2013)

A new initiative which aims for “a world free of cancer by 2050” has been launched in the US, stressing the need for more patient-centred innovation and an appreciation of the economic benefits of new cancer drugs.

NICE’s War Against the Rising Cost of Innovation

Ben Steele, (Jun 5, 2013)

Ben Steele talks with Sarah Garner, Associate Director of R&D at NICE, about the rising cost of pharma R&D, and how NICE plans to combat this trend by examining the role of real world data in reducing the costs of innovation.